Literature DB >> 25814212

Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients.

Alexander Breitenstein1, Martina Glanzmann2, Volkmar Falk3, Francesco Maisano3, Simon F Stämpfli4, Erik W Holy4, Malcolm Finlay5, Liang-Han Ling6, Richard J Schilling6, Thomas F Lüscher4, Jan Steffel4, Giovanni G Camici7.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is associated with an increased risk for thromboembolic events. While observational data demonstrated that the majority of clots are formed within the left atrial appendage, the mechanisms behind this finding remain unclear also due to the fact that vitro studies so far have been hampered by the inability to isolate and culture cells from the atrial appendages.
METHODS: Patients suffering from AF undergoing cardiac surgery were recruited for this study and endocardial cells from their left (LAA) and right atrial appendage (RAA) were isolated and cultured according to a novel established protocol. Once in culture, cells were stimulated with TNF-α (10 ng/mL) and the expression of prothrombotic as well as proinflammatory markers was analyzed.
RESULTS: FACS analysis confirmed a high purity (98%) of isolated LAA endocardial cells. TNF-α significantly increased tissue factor (TF) and PAI-1 expression (n=5; P<0.005), while TFPI remained unchanged. Similarly, expression of VCAM-1 was significantly higher in the LAA as compared to the RAA (n=5; P<0.0001).
CONCLUSION: According to our newly established cell isolation protocol, this study reveals that in patients with AF, the endocardium of the LAA displays an increased prothrombotic and proinflammatory profile as compared to the RAA. This novel observation may constitute an important mechanism to explain the increased propensity of the LAA for clot formation, as well as the predominance of LAA-related thromboembolic complications in AF patients, and may have important implications for the development of novel treatment strategies.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Atrial fibrillation; Clot formation; Endocardial cells; Left atrial appendage; Tissue factor

Mesh:

Substances:

Year:  2015        PMID: 25814212     DOI: 10.1016/j.ijcard.2015.03.092

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.

Authors:  Fabio Marsico; Milena Cecere; Antonio Parente; Stefania Paolillo; Fabiana de Martino; Santo Dellegrottaglie; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

2.  Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.

Authors:  Karin Willeit; Raimund Pechlaner; Peter Willeit; Philipp Skroblin; Bernhard Paulweber; Christiana Schernthaner; Thomas Toell; Georg Egger; Siegfried Weger; Martin Oberhollenzer; Ludmilla Kedenko; Bernhard Iglseder; Enzo Bonora; Georg Schett; Manuel Mayr; Johann Willeit; Stefan Kiechl
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

Review 3.  Cardiac natriuretic peptides.

Authors:  Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold
Journal:  Nat Rev Cardiol       Date:  2020-05-22       Impact factor: 32.419

Review 4.  The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties.

Authors:  Joshua O Cerasuolo; Lauren E Cipriano; Luciano A Sposato
Journal:  Curr Opin Neurol       Date:  2017-02       Impact factor: 5.710

Review 5.  Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation.

Authors:  Katarzyna Dudziñska-Szczerba; Piotr Kułakowski; Ilona Michałowska; Jakub Baran
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

6.  Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.

Authors:  Christina Christersson; Lars Wallentin; Ulrika Andersson; John H Alexander; Marco Alings; Raffaele De Caterina; Bernard J Gersh; Christopher B Granger; Sigrun Halvorsen; Michael Hanna; Kurt Huber; Elaine M Hylek; Renato D Lopes; Byung-Hee Oh; Agneta Siegbahn
Journal:  Heart       Date:  2018-09-12       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.